Ekso Bionics Holdings Inc (EKSO)

[skepticone]

I just finished reading that article and was going to post it and saw you had already done so. That pretty much sums up what I have been thinking for a while.

"Well, for us, these developments don’t really matter – at least not now. Sure, Artemis has great potential and TALOS is neat (and potentially lucrative, if the thing ever gets off the ground), but what Ekso really needs to do is allocated its resources towards selling the tech it’s already gotten developed and approved in the US, its stroke and spinal injury exoskeleton. Shareholders want to see a return on the time and capital that went into developing this tech (and it’s this technology that the company spent its time pitching as being at the core of its potential revaluation to the upside when it raised capital in the past) and, right now, things seem to be moving pretty slowly on that front."